Smoke Inhalation Injury in Patients Admitted to Intensive Care

NCT03834246 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2019-02-07

No results posted yet for this study

Summary

Many Studies have shown that the smoke-inhalation injury is responsible for a high mortality mainly related to the systemic effects of carbon monoxide and cyanide. Respiratory lesions induced by smoke inhalation, is one of predictive factors of mortality.

The aim of the study is to identify the clinical and epidemiological characteristics of smoke-inhalation injury and to identify prognostic factors among these patients .

Conditions

  • Smoke Inhalation Injury
  • Morality

Sponsors & Collaborators

  • Centre d'Investigation Clinique et Technologique 805

    lead OTHER

Principal Investigators

  • Rania BOUNAB, dr · Raymond Poincaré Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-16
Primary Completion
2019-12-31
Completion
2020-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03834246 on ClinicalTrials.gov